Patent ID: 8497240

Claim:
A gastric inhibitory polypeptide (GIP) compound that is a GIP hybrid polypeptide exhibiting at least two hormonal activities, said polypeptide comprising a first bio-active peptide hormone module that comprises 0601GIP5082 (SEQ ID NO: 878) that is covalently linked to at least one additional bio-active peptide hormone module; wherein: the at least one additional bio-active peptide hormone module is selected from the group consisting of: component peptide hormones, fragments of component peptide hormones that exhibit at least one hormonal activity of the component peptide hormones, analogs and derivatives of component peptide hormones that exhibit at least one hormonal activity of the component peptide hormones, and fragments of analogs and derivatives of component peptide hormones that exhibit at least one hormonal activity of the component peptide hormones; the component peptide hormone of the at least one additional bio-active peptide hormone module is selected from the group consisting of: amylin family peptides; and the first bio-active peptide hormone module exhibits at least one GIP hormonal activity and the at least one additional bio-active peptide hormone module exhibits at least one amylin hormonal activity.